GMED

GMED

GMED

Letters With This Ticker

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Keywords/Themes	Theme Commentary	Pitches	Letter
2025 Q3	Sep 30, 2025	Antipodes Global Fund	-	-	4063 JP, 6367 JP, 6702 JP, ASAIY, B, EAT, GMED, GOOG, MPNGY, MRK, NG, PCOR, TCEHY, UBS, VALT LN	AI, Capex, Cloud, Platforms, semiconductors	AI-driven equity momentum remains the dominant global market catalyst, influencing U.S. leadership, Chinas tech rally, and sector performance. The fund highlights both opportunity and risk in AI-related capital expenditure cycles, with concerns over circular investment dynamics. AI continues to shape earnings dispersion, regulatory focus, and positioning across global equities.		View
2025 Q3	Sep 30, 2025	Antipodes Global Value Fund	-	-	4063 JP, 6367 JP, 6702 JP, ASAIY, B, BABA, EAT, GMED, GOOG, MPNGY, MRK, PCOR, TCEHY, VALT LN	AI, China, Cloud, Platforms, semiconductors	AI optimism fuels U.S. tech strength and Chinas policy-supported chip and platform expansion, driving major contributors such as Alphabet, Tencent, and Alibaba. The fund emphasizes AI monetization across cloud, gaming, advertising, and silicon supply chains. AI remains a central multiyear growth engine shaping valuation, sector rotation, and capital allocation.	GOLD US 6367 JP GMED US PCOR US 4063 JP 300750 CH GOLD US	View
2025 Q2	Jul 10, 2025	Headwaters Capital Management, LLC	7.3%	-2.6%	GMED, TECH, TMDX	AI, Rotation, small caps, valuation		TECH	View
2025 Q4	Feb 17, 2026	AMG GW&K Small Cap Core Fund	3.5%	7.2%	AEIS, AGIO, CIFR, CSWI, CVLT, DAVA, DSGX, FLYW, GMED, HUT, INTA, ITT, MTSI, PAR, QBTS, RARE, RBC, SATS, SF, SKY, SLG, SPXC, STRL, SUPN, THR, VIAV, WULF	healthcare, industrials, materials, Quality, small caps, technology, Trade Policy, value	The Russell 2000 Index delivered 12.8% returns for 2025 despite significant volatility, with a 23% drop by April followed by a 40% recovery. The small cap environment was characterized by narrow performance driven by low-quality, speculative stocks, with the top 25 contributors delivering over 50% of benchmark returns. The investment environment overwhelmingly favored lower quality stocks, with non-earners gaining 19.6%, negative equity stocks up 37.2%, and highest beta names advancing 26.1%. The fund's deliberate focus on higher-quality stocks with earnings support was a general headwind throughout the year. Artificial intelligence investment was a key area of market focus during 2025, though the fund questioned when investors would see returns from billions of dollars spent on AI infrastructure. The fund avoided speculative AI plays in favor of companies with more established fundamentals. Uncertain trade policy and the friction it added to the system was the biggest distraction during 2025. Companies now mostly have a sense of the rules of global trade and are adjusting, which could provide more stability going forward.		View
2025 Q4	Jan 30, 2026	Invesco Small Cap Value Fund	6.8%	17.6%	ACM, ARCB, COHR, CR, CRL, ENTG, EXPE, GL, GMED, HBM.TO, KBR, LITE, MKSI, NRG, PENN, SAIA, WAL, WBS	AI, Biotech, financials, healthcare, Intrinsic Value, small cap, technology, value	The fund employs an intrinsic value approach to stock selection, seeking companies significantly undervalued on an absolute basis. At quarter end, the difference between market prices and intrinsic value estimates was attractive, indicating potential long-term capital appreciation. Small-cap value stocks appear attractive relative to S&P 500 Index stocks. Following outperformance of large-cap stocks over small-cap stocks in recent years, the managers see greater long-term upside to intrinsic value in many small-caps compared to large-caps. The Russell 2000 Value Index P/E multiple has been at a historical discount compared to the S&P 500 Index P/E. The fund benefited from AI-driven growth potential in holdings like Lumentum, which rallied due to investor enthusiasm for its AI applications. ArcBest's operational efficiency and technological advancements using artificial intelligence should position the company well for demand recovery in trucking.	LITE GTLB ARCB GMED CRL	View
2025 Q4	Jan 21, 2026	Meridian Growth Fund	-0.4%	-6.4%	ABT, CERT, CHDN, COO, DOCS, DT, EXAS, GFS, GMED, RELY, SAIC, TNDM, TPB, TRMB, VCYT	growth, healthcare, Medical Devices, Quality, small caps, technology	Healthcare was the portfolio's largest allocation and top-performing sector for the quarter, with the fund maintaining an overweight position. The manager views healthcare as undervalued relative to long-term fundamentals after lagging the broader market for four years. Several healthcare holdings contributed positively including medical device companies and diagnostics firms. The fund's investment approach emphasizes high-quality businesses with recurring revenue, sustainable competitive advantages, and strong balance sheets. However, the quarter saw relative outperformance by lower-quality stocks which created a modest headwind to performance given the portfolio's quality bias. The fund focuses on small-cap growth investments, benchmarked against the Russell 2500 Growth Index. Small caps delivered solid annual returns of 12.8% for the year, though below large-cap returns, with value outperforming growth in the quarter.		View
2023 Q1	Apr 14, 2023	Madison Small Cap Fund	6.3%	17.2%	GMED, NATI, TCBI, XMTR	-			View
2023 Q1	Mar 31, 2023	Cove Street Capital Small Cap Value Fund	3.7%	-6.0%	CLMB, CMP, ECVT, GLDD, GMED, HNRG, LFCR, LGF/B, NUVA, SSP, TIGO, VMD	-			View

Pitches With This Ticker

Date	Pitch Type	Author	Company	Industry	Sub Industry	Bull / Bear	Stock Exchange	Keywords	Action
Feb 4, 2026	Fund Letters	Jonathan Edwards	Globus Medical	Health Care	Medical Devices	Bull	New York Stock Exchange	Integration-Risk, Medical devices, Orthopedics, recovery, Spine	View Pitch
Jan 24, 2026	Fund Letters	Chad Meade	Globus Medical, Inc.	Health Care	Health Care Equipment	Bull	New York Stock Exchange	Acquisitions, growth, leverage, Medtech, Spine	View Pitch
Aug 13, 2025	Seeking Alpha	The Value Investor	Globus Medical	Health Care	Medical Devices	Bull	NYSE	—	View Pitch

BSD Shareholders of GMED

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025

Manager Name	Fund Name	Fund AUM	Invested Value	Portfolio Weight	Shares Owned	Shares Bought / Sold During Quarter	% Bought / Sold During Quarter	% of Shares Outstanding Owned
No investor data available.

Join for free and get access to the buyside

Get insights from the world's most influential hedge fund investors direct to your inbox

Follow Us On: